| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | C01BA13 |
| UNII: | 8P68XPY4HG |
Structure
| InChI Key | LJOQGZACKSYWCH-NBGVHYBESA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C20H26N2O2 |
| Molecular Weight | 326.44 |
| AlogP | 3.4 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 45.59 |
| Molecular species | BASE |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 24.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 78 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Brugada Syndrome | 3 | D053840 | ClinicalTrials |
Related Entries
MCS
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1435-55-8 |
| ChEBI | 5792 |
| ChEMBL | CHEMBL1906890 |
| FDA SRS | 8P68XPY4HG |
| KEGG | C10696 |
| PubChem | 91503 |
| SureChEMBL | SCHEMBL13587300 |
CONTENTS